Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydromorphone | 1 | 2024 | 5 | 0.950 |
Why?
|
| Pneumonia, Ventilator-Associated | 3 | 2013 | 33 | 0.900 |
Why?
|
| Fentanyl | 1 | 2024 | 72 | 0.890 |
Why?
|
| Respiration, Artificial | 2 | 2024 | 292 | 0.790 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 483 | 0.660 |
Why?
|
| Pharmacy Service, Hospital | 2 | 2019 | 21 | 0.610 |
Why?
|
| Medication Reconciliation | 1 | 2014 | 13 | 0.450 |
Why?
|
| Students, Pharmacy | 1 | 2014 | 12 | 0.440 |
Why?
|
| Pharmacists | 2 | 2018 | 123 | 0.430 |
Why?
|
| Pneumonia, Bacterial | 1 | 2013 | 88 | 0.390 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2012 | 53 | 0.390 |
Why?
|
| Bacterial Infections | 1 | 2012 | 140 | 0.360 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2020 | 119 | 0.270 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 735 | 0.270 |
Why?
|
| Intensive Care Units | 3 | 2024 | 423 | 0.220 |
Why?
|
| Critical Illness | 4 | 2020 | 325 | 0.200 |
Why?
|
| Hypnotics and Sedatives | 2 | 2020 | 62 | 0.170 |
Why?
|
| Tachycardia | 1 | 2020 | 28 | 0.170 |
Why?
|
| Dexmedetomidine | 1 | 2020 | 9 | 0.170 |
Why?
|
| Cross Infection | 2 | 2012 | 149 | 0.170 |
Why?
|
| Pharmacy Residencies | 1 | 2019 | 1 | 0.170 |
Why?
|
| Aged | 6 | 2024 | 13408 | 0.160 |
Why?
|
| Cohort Studies | 1 | 2024 | 2375 | 0.150 |
Why?
|
| Blood Coagulation Factors | 1 | 2018 | 13 | 0.150 |
Why?
|
| Plasma | 1 | 2018 | 35 | 0.140 |
Why?
|
| Retrospective Studies | 3 | 2024 | 6072 | 0.140 |
Why?
|
| Middle Aged | 5 | 2024 | 16314 | 0.140 |
Why?
|
| Warfarin | 1 | 2018 | 105 | 0.140 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 166 | 0.140 |
Why?
|
| Hemorrhage | 1 | 2018 | 260 | 0.130 |
Why?
|
| Benzodiazepines | 1 | 2016 | 94 | 0.130 |
Why?
|
| Critical Care | 1 | 2019 | 397 | 0.120 |
Why?
|
| Male | 7 | 2024 | 27750 | 0.120 |
Why?
|
| Humans | 11 | 2024 | 59390 | 0.120 |
Why?
|
| Hypertension | 1 | 2020 | 570 | 0.120 |
Why?
|
| Female | 7 | 2024 | 30727 | 0.110 |
Why?
|
| General Practice | 1 | 2014 | 15 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2018 | 480 | 0.110 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2013 | 43 | 0.100 |
Why?
|
| Nurses | 1 | 2014 | 102 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 100 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2012 | 191 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1480 | 0.090 |
Why?
|
| Long-Term Care | 1 | 2012 | 176 | 0.090 |
Why?
|
| Infection Control | 1 | 2012 | 94 | 0.090 |
Why?
|
| Anti-Ulcer Agents | 1 | 2010 | 8 | 0.090 |
Why?
|
| Histamine H2 Antagonists | 1 | 2010 | 10 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 442 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 931 | 0.090 |
Why?
|
| Proton Pump Inhibitors | 1 | 2010 | 33 | 0.080 |
Why?
|
| Risk Factors | 3 | 2020 | 4987 | 0.080 |
Why?
|
| Anesthetics, Intravenous | 1 | 2009 | 23 | 0.080 |
Why?
|
| Propofol | 1 | 2009 | 21 | 0.080 |
Why?
|
| Clostridium Infections | 1 | 2010 | 45 | 0.080 |
Why?
|
| Physicians | 1 | 2014 | 440 | 0.080 |
Why?
|
| Age Factors | 1 | 2012 | 1504 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 5119 | 0.070 |
Why?
|
| Time Factors | 2 | 2012 | 3618 | 0.070 |
Why?
|
| Hospitalization | 1 | 2014 | 1292 | 0.070 |
Why?
|
| Incidence | 1 | 2009 | 1238 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2020 | 1051 | 0.050 |
Why?
|
| Adult | 3 | 2016 | 15681 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 805 | 0.050 |
Why?
|
| Length of Stay | 2 | 2016 | 776 | 0.040 |
Why?
|
| Education, Pharmacy | 1 | 2019 | 17 | 0.040 |
Why?
|
| Mentors | 1 | 2019 | 116 | 0.040 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 32 | 0.040 |
Why?
|
| Professional Role | 1 | 2018 | 39 | 0.040 |
Why?
|
| Pharmaceutical Services | 1 | 2018 | 31 | 0.040 |
Why?
|
| Lorazepam | 1 | 2016 | 8 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 284 | 0.030 |
Why?
|
| Internet | 1 | 2019 | 448 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2018 | 526 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2016 | 136 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2018 | 327 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 2382 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2010 | 3067 | 0.030 |
Why?
|
| Synbiotics | 1 | 2012 | 4 | 0.020 |
Why?
|
| Oral Hygiene | 1 | 2012 | 12 | 0.020 |
Why?
|
| Hand Disinfection | 1 | 2012 | 15 | 0.020 |
Why?
|
| Chlorhexidine | 1 | 2012 | 17 | 0.020 |
Why?
|
| Ventilator Weaning | 1 | 2012 | 19 | 0.020 |
Why?
|
| Gastrointestinal Agents | 1 | 2012 | 25 | 0.020 |
Why?
|
| Disinfectants | 1 | 2012 | 21 | 0.020 |
Why?
|
| Patient Positioning | 1 | 2012 | 44 | 0.020 |
Why?
|
| Probiotics | 1 | 2012 | 44 | 0.020 |
Why?
|
| Inservice Training | 1 | 2012 | 81 | 0.020 |
Why?
|
| Drainage | 1 | 2012 | 150 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2010 | 10 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 297 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 2012 | 194 | 0.020 |
Why?
|
| Propensity Score | 1 | 2010 | 144 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 170 | 0.020 |
Why?
|
| Boston | 1 | 2010 | 247 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 396 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2009 | 145 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 902 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 308 | 0.020 |
Why?
|
| Heart Failure | 1 | 2009 | 853 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 5283 | 0.010 |
Why?
|